PlainPill

RAD-140 vs Retatrutide for weight loss

Short answer: For weight loss, users rate them about the same: 93% report improvement with RAD-140 (61 reports) and 92% with Retatrutide (228 reports).

RAD-140 has 0 meta-analyses and 0 randomized trials on PubMed; Retatrutide has 22 and 6.

Based on 873 reports about RAD-140 and 460 about Retatrutide. Not medical advice.

RAD-140
SARM
Retatrutide
Peptide
Users say it helped42%helped541 reports · high confidence76%helped327 reports · high confidence
Verdict
Mixed
Mostly positive
ResearchDResearch: NoneBResearch: Moderate
Meta-analyses / RCTs0 / 022 / 6
Mainly used for
Performance
% reporting improvement
93% (371)82% (33)
Weight loss
% reporting improvement
93% (61)92% (228)
Energy
% reporting improvement
44% (64)69% (75)
Appetite
% reporting improvement
60% (10)73% (86)
Mood
% reporting improvement
37% (63)66% (32)
Common side effectssuppression, hair loss, insomnia, fatiguenausea, fatigue, stomach issues, insomnia
Typical dose reportedNot listedNot listed
RAD-140
What a user said
“I did put on decent size and I feel a lot fuller. My strength and endurance has gone up tremendously. Side effects - Shedding of hair, anxiety...”
Full RAD-140 profile →
Retatrutide
Latest review conclusion

This systematic review identifies the state and mechanism of action of emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials. The information provided herein furthers the understanding of obesity management, implying direct clinical implications and stimulating research initiatives.

Pharmacol Rev, 2025 ↗
What a user said
“Drastically reduced appetite: At 5mg, I experienced near-total suppression of hunger and cravings. Steady, effortless fat loss: I didn't have to track macros obsessively or do extreme cardio.”
Full Retatrutide profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate